P. Schoenfeld Asset Management (PSAM)’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,000	Closed	-$6.46K	–	59
2023 Q4	$6.46K	Hold	80,000	–	–	﹤0.01%	61
2023 Q3	$31.6K	Hold	80,000	–	–	﹤0.01%	82
2023 Q2	$16.8K	Hold	80,000	–	–	﹤0.01%	86
2023 Q1	$11.2K	Hold	80,000	–	–	﹤0.01%	124
2022 Q4	$6.79K	Hold	80,000	–	–	﹤0.01%	176
2022 Q3	$12K	Hold	80,000	–	–	﹤0.01%	258
2022 Q2	$21K	Hold	80,000	–	–	﹤0.01%	301
2022 Q1	$49K	Buy	+80,000	New	+$66.6K	﹤0.01%	344

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s NKGNW Position: Q1 2024 in Review

P. Schoenfeld Asset Management (PSAM) sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2024, closing a stake of 80,000 shares — an estimated $6.46K sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in NKGNW in Q1 2022 and held it in 8 quarters. The position peaked at $49K in Q1 2022. 30 funds tracked by Wall St. Rank hold NKGNW as of Q1 2024.

P. Schoenfeld Asset Management (PSAM) reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2024 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 80,000 NKGen Biotech, Inc. Warrants shares in Q1 2024, an estimated $6.46K.
P. Schoenfeld Asset Management (PSAM) first reported a position in NKGen Biotech, Inc. Warrants in Q1 2022 and held it in 8 quarters.
P. Schoenfeld Asset Management (PSAM)'s NKGen Biotech, Inc. Warrants position peaked at $49K in Q1 2022.
30 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2024.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q1 2024, filed 15 May 2024.